Clinical trials
Completed Schizophrenia Spectrum and Other Psychotic Disorders trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2006 | 2 |
| 2009 | 3 |
| 2012 | 1 |
| 2015 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Minnesota | 3 |
| AbbVie | 2 |
| National Institute on Drug Abuse (NIDA) | 2 |
| Yale University | 2 |
| Brown University | 1 |
| Center for Social Innovation, Massachusetts | 1 |
| Cerevel Therapeutics, LLC | 1 |
| Luye Pharma Group Ltd. | 1 |
| Massachusetts General Hospital | 1 |
| Merck Sharp & Dohme LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Schizophrenia Spectrum and Other Psychotic Disorders | 22 |
| Schizophrenia | 14 |
| Mental Disorders | 10 |
| Psychotic Disorders | 10 |
| Tobacco Use Disorder | 3 |
| Mood Disorders | 2 |
| Affective Disorders, Psychotic | 1 |
| Anxiety Disorders | 1 |
| Attention Deficit Disorder with Hyperactivity | 1 |
| Bipolar and Related Disorders | 1 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.